Matches in SemOpenAlex for { <https://semopenalex.org/work/W2743242016> ?p ?o ?g. }
- W2743242016 endingPage "2463" @default.
- W2743242016 startingPage "2457" @default.
- W2743242016 abstract "Background and Purpose— In patients receiving direct oral anticoagulants (DOACs), emergency treatment like thrombolysis for acute ischemic stroke is complicated by insufficient availability of DOAC-specific coagulation tests. Conflicting recommendations have been published concerning the use of global coagulation assays for ruling out relevant DOAC-induced anticoagulation. Methods— Four hundred eighty-one samples from 96 DOAC-treated patients were tested using prothrombin time (PT), activated partial thromboplastin time (aPTT) and thrombin time (TT), DOAC-specific assays (anti-Xa activity, diluted TT), and liquid chromatography–tandem mass spectrometry. Sensitivity and specificity of test results to identify DOAC concentrations <30 ng/mL were calculated. Receiver operating characteristic analyses were used to define reagent-specific cutoff values. Results— Normal PT and aPTT provide insufficient specificity to safely identify DOAC concentrations <30 ng/mL (rivaroxaban/PT: specificity, 77%/sensitivity, 94%; apixaban/PT: specificity, 13%/sensitivity, 94%, dabigatran/aPTT: specificity, 49%/sensitivity, 91%). Normal TT was 100% specific for dabigatran, but sensitivity was 26%. In contrast, reagent-specific PT and aPTT cutoffs provided >95% specificity and a specific TT cutoff enhanced sensitivity for dabigatran to 84%. For apixaban, no cutoffs could be established. Conclusions— Even if highly DOAC-reactive reagents are used, normal results of global coagulation tests are not suited to guide emergency treatment: whereas normal PT and aPTT lack specificity to rule out DOAC-induced anticoagulation, the low sensitivity of normal TT excludes the majority of eligible patients from treatment. However, reagent-specific cutoffs for global coagulation tests ensure high specificity and optimize sensitivity for safe emergency decision making in rivaroxaban- and dabigatran-treated patients. Clinical Trial Registration— URL: http://www.clinicaltrials.gov . Unique identifiers: NCT02371044 and NCT02371070." @default.
- W2743242016 created "2017-08-17" @default.
- W2743242016 creator A5002648105 @default.
- W2743242016 creator A5005980383 @default.
- W2743242016 creator A5007815473 @default.
- W2743242016 creator A5010931202 @default.
- W2743242016 creator A5012501589 @default.
- W2743242016 creator A5019671722 @default.
- W2743242016 creator A5029088467 @default.
- W2743242016 creator A5056182768 @default.
- W2743242016 creator A5056393712 @default.
- W2743242016 creator A5070374515 @default.
- W2743242016 date "2017-09-01" @default.
- W2743242016 modified "2023-09-30" @default.
- W2743242016 title "Emergency Coagulation Assessment During Treatment With Direct Oral Anticoagulants" @default.
- W2743242016 cites W1604344130 @default.
- W2743242016 cites W1862944133 @default.
- W2743242016 cites W1870017071 @default.
- W2743242016 cites W1967894356 @default.
- W2743242016 cites W1981340953 @default.
- W2743242016 cites W1997970906 @default.
- W2743242016 cites W2000922667 @default.
- W2743242016 cites W2001598988 @default.
- W2743242016 cites W2033430377 @default.
- W2743242016 cites W2033489828 @default.
- W2743242016 cites W2041263654 @default.
- W2743242016 cites W2046188252 @default.
- W2743242016 cites W2142496965 @default.
- W2743242016 cites W2153134011 @default.
- W2743242016 cites W2154095719 @default.
- W2743242016 cites W2157224841 @default.
- W2743242016 cites W2159577033 @default.
- W2743242016 cites W2161264907 @default.
- W2743242016 cites W2164363187 @default.
- W2743242016 cites W2198635349 @default.
- W2743242016 cites W2208273214 @default.
- W2743242016 cites W2464621567 @default.
- W2743242016 cites W2557371738 @default.
- W2743242016 cites W2588575739 @default.
- W2743242016 cites W2595894510 @default.
- W2743242016 cites W826970266 @default.
- W2743242016 doi "https://doi.org/10.1161/strokeaha.117.017981" @default.
- W2743242016 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28775134" @default.
- W2743242016 hasPublicationYear "2017" @default.
- W2743242016 type Work @default.
- W2743242016 sameAs 2743242016 @default.
- W2743242016 citedByCount "34" @default.
- W2743242016 countsByYear W27432420162017 @default.
- W2743242016 countsByYear W27432420162018 @default.
- W2743242016 countsByYear W27432420162019 @default.
- W2743242016 countsByYear W27432420162020 @default.
- W2743242016 countsByYear W27432420162021 @default.
- W2743242016 countsByYear W27432420162022 @default.
- W2743242016 countsByYear W27432420162023 @default.
- W2743242016 crossrefType "journal-article" @default.
- W2743242016 hasAuthorship W2743242016A5002648105 @default.
- W2743242016 hasAuthorship W2743242016A5005980383 @default.
- W2743242016 hasAuthorship W2743242016A5007815473 @default.
- W2743242016 hasAuthorship W2743242016A5010931202 @default.
- W2743242016 hasAuthorship W2743242016A5012501589 @default.
- W2743242016 hasAuthorship W2743242016A5019671722 @default.
- W2743242016 hasAuthorship W2743242016A5029088467 @default.
- W2743242016 hasAuthorship W2743242016A5056182768 @default.
- W2743242016 hasAuthorship W2743242016A5056393712 @default.
- W2743242016 hasAuthorship W2743242016A5070374515 @default.
- W2743242016 hasBestOaLocation W27432420161 @default.
- W2743242016 hasConcept C126322002 @default.
- W2743242016 hasConcept C16124881 @default.
- W2743242016 hasConcept C2776301958 @default.
- W2743242016 hasConcept C2778261982 @default.
- W2743242016 hasConcept C2778382381 @default.
- W2743242016 hasConcept C2778661090 @default.
- W2743242016 hasConcept C2778810321 @default.
- W2743242016 hasConcept C2779161974 @default.
- W2743242016 hasConcept C2780077467 @default.
- W2743242016 hasConcept C2780434524 @default.
- W2743242016 hasConcept C2780638905 @default.
- W2743242016 hasConcept C42219234 @default.
- W2743242016 hasConcept C71924100 @default.
- W2743242016 hasConcept C90924648 @default.
- W2743242016 hasConceptScore W2743242016C126322002 @default.
- W2743242016 hasConceptScore W2743242016C16124881 @default.
- W2743242016 hasConceptScore W2743242016C2776301958 @default.
- W2743242016 hasConceptScore W2743242016C2778261982 @default.
- W2743242016 hasConceptScore W2743242016C2778382381 @default.
- W2743242016 hasConceptScore W2743242016C2778661090 @default.
- W2743242016 hasConceptScore W2743242016C2778810321 @default.
- W2743242016 hasConceptScore W2743242016C2779161974 @default.
- W2743242016 hasConceptScore W2743242016C2780077467 @default.
- W2743242016 hasConceptScore W2743242016C2780434524 @default.
- W2743242016 hasConceptScore W2743242016C2780638905 @default.
- W2743242016 hasConceptScore W2743242016C42219234 @default.
- W2743242016 hasConceptScore W2743242016C71924100 @default.
- W2743242016 hasConceptScore W2743242016C90924648 @default.
- W2743242016 hasIssue "9" @default.
- W2743242016 hasLocation W27432420161 @default.
- W2743242016 hasLocation W27432420162 @default.
- W2743242016 hasOpenAccess W2743242016 @default.